Literature DB >> 26392628

Shared Immune and Repair Markers During Experimental Toxoplasma Chronic Brain Infection and Schizophrenia.

Jakub Tomasik1, Tracey L Schultz2, Wolfgang Kluge3, Robert H Yolken4, Sabine Bahn1, Vern B Carruthers5.   

Abstract

Chronic neurologic infection with Toxoplasma gondii is relatively common in humans and is one of the strongest known risk factors for schizophrenia. Nevertheless, the exact neuropathological mechanisms linking T gondii infection and schizophrenia remain unclear. Here we utilize a mouse model of chronic T gondii infection to identify protein biomarkers that are altered in serum and brain samples at 2 time points during chronic infection. Furthermore, we compare the identified biomarkers to those differing between "postmortem" brain samples from 35 schizophrenia patients and 33 healthy controls. Our findings suggest that T gondii infection causes substantial and widespread immune activation indicative of neural damage and reactive tissue repair in the animal model that partly overlaps with changes observed in the brains of schizophrenia patients. The overlapping changes include increases in C-reactive protein (CRP), interleukin-1 beta (IL-1β), interferon gamma (IFNγ), plasminogen activator inhibitor 1 (PAI-1), tissue inhibitor of metalloproteinases 1 (TIMP-1), and vascular cell adhesion molecule 1 (VCAM-1). Potential roles of these factors in the pathogenesis of schizophrenia and toxoplasmosis are discussed. Identifying a defined set of markers shared within the pathophysiological landscape of these diseases could be a key step towards understanding their specific contributions to pathogenesis.
© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Toxoplasma gondii; animal model; biomarker

Mesh:

Substances:

Year:  2015        PMID: 26392628      PMCID: PMC4753603          DOI: 10.1093/schbul/sbv134

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  58 in total

Review 1.  Kynurenines: from the perspective of major psychiatric disorders.

Authors:  Aye M Myint
Journal:  FEBS J       Date:  2012-03-27       Impact factor: 5.542

Review 2.  Toxoplasma gondii-induced neuronal alterations.

Authors:  A Parlog; D Schlüter; I R Dunay
Journal:  Parasite Immunol       Date:  2015-03       Impact factor: 2.280

3.  Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: voxel-based-morphometry (VBM) study.

Authors:  Jiri Horacek; Jaroslav Flegr; Jaroslav Tintera; Karin Verebova; Filip Spaniel; Tomas Novak; Martin Brunovsky; Vera Bubenikova-Valesova; David Holub; Tomas Palenicek; Cyril Höschl
Journal:  World J Biol Psychiatry       Date:  2011-05-23       Impact factor: 4.132

4.  A thiazole derivative of artemisinin moderately reduces Toxoplasma gondii cyst burden in infected mice.

Authors:  Tracey L Schultz; Christopher P Hencken; Lauren E Woodard; Gary H Posner; Robert H Yolken; Lorraine Jones-Brando; Vern B Carruthers
Journal:  J Parasitol       Date:  2014-02-13       Impact factor: 1.276

5.  A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice.

Authors:  Y Suzuki; K Joh; M A Orellana; F K Conley; J S Remington
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

Review 6.  Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism.

Authors:  M W Taylor; G S Feng
Journal:  FASEB J       Date:  1991-08       Impact factor: 5.191

7.  C-reactive protein is elevated in schizophrenia.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Crystal Vaughan; Sunil Khushalani; Shuojia Yang; Robert Yolken
Journal:  Schizophr Res       Date:  2012-12-04       Impact factor: 4.939

8.  Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.

Authors:  F M Notarangelo; E H Wilson; K J Horning; M A R Thomas; T H Harris; Q Fang; C A Hunter; R Schwarcz
Journal:  Schizophr Res       Date:  2013-12-15       Impact factor: 4.939

9.  Dual transcriptional profiling of mice and Toxoplasma gondii during acute and chronic infection.

Authors:  Kelly J Pittman; Matthew T Aliota; Laura J Knoll
Journal:  BMC Genomics       Date:  2014-09-20       Impact factor: 3.969

Review 10.  Parasite zoonoses and wildlife: One Health, spillover and human activity.

Authors:  R C Andrew Thompson
Journal:  Int J Parasitol       Date:  2013-07-23       Impact factor: 3.981

View more
  10 in total

1.  Toxoplasma gondii infection and common mental disorders in the Finnish general population.

Authors:  Jaana Suvisaari; Minna Torniainen-Holm; Maija Lindgren; Tommi Härkänen; Robert H Yolken
Journal:  J Affect Disord       Date:  2017-07-10       Impact factor: 4.839

Review 2.  The known and missing links between Toxoplasma gondii and schizophrenia.

Authors:  Hany M Elsheikha; Dietrich Büsselberg; Xing-Quan Zhu
Journal:  Metab Brain Dis       Date:  2016-04-04       Impact factor: 3.584

3.  CSF-Based Analysis for Identification of Potential Serum Biomarkers of Neural Tube Defects.

Authors:  Xinyu Yan; Lixin Mai; Changchun Lin; Wenji He; Gengsheng Yin; Jiakang Yu; Lian Huang; Sanqiang Pan
Journal:  Neurosci Bull       Date:  2017-07-10       Impact factor: 5.203

4.  Besnoitia besnoiti infections activate primary bovine endothelial cells and promote PMN adhesion and NET formation under physiological flow condition.

Authors:  P Maksimov; C Hermosilla; S Kleinertz; J Hirzmann; A Taubert
Journal:  Parasitol Res       Date:  2016-02-05       Impact factor: 2.289

5.  From Toxoplasmosis to Schizophrenia via NMDA Dysfunction: Peptide Overlap between Toxoplasma gondii and N-Methyl-d-Aspartate Receptors As a Potential Mechanistic Link.

Authors:  Guglielmo Lucchese
Journal:  Front Psychiatry       Date:  2017-03-15       Impact factor: 4.157

6.  Environmental risk factors for Toxoplasma gondii infections and the impact of latent infections on allostatic load in residents of Central North Carolina.

Authors:  Andrey I Egorov; Reagan Converse; Shannon M Griffin; Jennifer Styles; Elizabeth Klein; Elizabeth Sams; Edward Hudgens; Timothy J Wade
Journal:  BMC Infect Dis       Date:  2018-08-23       Impact factor: 3.090

7.  Latent Toxoplasma gondii infections are associated with elevated biomarkers of inflammation and vascular injury.

Authors:  Andrey I Egorov; Reagan R Converse; Shannon M Griffin; Jennifer N Styles; Elizabeth Sams; Edward Hudgens; Timothy J Wade
Journal:  BMC Infect Dis       Date:  2021-02-18       Impact factor: 3.090

8.  Back to the Future: The Role of Infections in Psychopathology. Focus on OCD.

Authors:  Alessandra Della Vecchia; Donatella Marazziti
Journal:  Clin Neuropsychiatry       Date:  2022-08

9.  Toxoplasma gondii infection damages the perineuronal nets in a murine model.

Authors:  Ywlliane da Silva Rodrigues Meurer; Ramayana Morais de Medeiros Brito; Valeria Palheta da Silva; Joelma Maria de Araujo Andade; Sarah Sophia Guedes Linhares; Antonio Pereira Junior; Valter Ferreira de Andrade-Neto; Andrea Lima de Sá; Claudio Bruno Silva de Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  2020-09-11       Impact factor: 2.743

10.  Hepatitis C-associated late-onset schizophrenia: a nationwide, population-based cohort study.

Authors:  Jur-Shan Cheng; Jing-Hong Hu; Ming-Yu Chang; Ming-Shyan Lin; Hsin-Ping Ku; Rong-Nan Chien; Ming-Ling Chang
Journal:  J Psychiatry Neurosci       Date:  2021-11-02       Impact factor: 6.186

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.